Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Yagi

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2022
Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogensHironori Kobayashi, Yuichiro Shindo, Daisuke Kobayashi, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 2, 2011
Virus-associated hemophagocytic syndrome caused by pandemic swine-origin influenza A (H1N1) in a patient after unrelated bone marrow transplantationAkira Katsumi, Tetsuya Nishida, Makoto Murata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 27, 2018
Active surveillance in response to the identification of a single carbapenemase-producing Escherichia coli at a Japanese university hospitalDaizo Kato, Hiroshi Morioka, Yuka Tomita, et al.
American Journal of Infection Control|July 4, 2016
The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot studyHiroshi Morioka, Aki Hirabayashi, Mitsutaka Iguchi, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolatesYasuhiro Horita, Takemasa Takii, Tetsuya Yagi, et al.
Infection and Drug Resistance|October 24, 2018
Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumoniaDaisuke Kobayashi, Yuichiro Shindo, Ryota Ito, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in JapanNaohiro Shibata, Hiroshi Kurokawa, Yohei Doi, et al.
BMC Infectious Diseases|August 31, 2021
Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trialNobuhisa Ishiguro, Yoichi M Ito, Sumio Iwasaki, et al.
CEN Case Reports|September 17, 2020
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019Eri Koshi, Shoji Saito, Masaki Okazaki, et al.
The Lancet. Infectious Diseases|July 7, 2015
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort studyYuichiro Shindo, Ryota Ito, Daisuke Kobayashi, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2022
Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogensHironori Kobayashi, Yuichiro Shindo, Daisuke Kobayashi, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 2, 2011
Virus-associated hemophagocytic syndrome caused by pandemic swine-origin influenza A (H1N1) in a patient after unrelated bone marrow transplantationAkira Katsumi, Tetsuya Nishida, Makoto Murata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 27, 2018
Active surveillance in response to the identification of a single carbapenemase-producing Escherichia coli at a Japanese university hospitalDaizo Kato, Hiroshi Morioka, Yuka Tomita, et al.
American Journal of Infection Control|July 4, 2016
The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot studyHiroshi Morioka, Aki Hirabayashi, Mitsutaka Iguchi, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolatesYasuhiro Horita, Takemasa Takii, Tetsuya Yagi, et al.
Infection and Drug Resistance|October 24, 2018
Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumoniaDaisuke Kobayashi, Yuichiro Shindo, Ryota Ito, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in JapanNaohiro Shibata, Hiroshi Kurokawa, Yohei Doi, et al.
BMC Infectious Diseases|August 31, 2021
Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trialNobuhisa Ishiguro, Yoichi M Ito, Sumio Iwasaki, et al.
CEN Case Reports|September 17, 2020
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019Eri Koshi, Shoji Saito, Masaki Okazaki, et al.
The Lancet. Infectious Diseases|July 7, 2015
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort studyYuichiro Shindo, Ryota Ito, Daisuke Kobayashi, et al.
Pageof 16